Literature DB >> 16737861

Targeting B cells in the treatment of childhood-onset systemic lupus erythematosus.

Jennifer L Huggins, Hermine I Brunner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16737861     DOI: 10.1016/j.jpeds.2006.03.011

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  5 in total

1.  Vitamin D status in children with systemic lupus erythematosus and its association with clinical and laboratory parameters.

Authors:  Alhanouf AlSaleem; Ashwaq AlE'ed; Afaf AlSaghier; Sulaiman M Al-Mayouf
Journal:  Clin Rheumatol       Date:  2014-11-04       Impact factor: 2.980

Review 2.  Pediatric SLE--towards a comprehensive management plan.

Authors:  Hermine I Brunner; Jennifer Huggins; Marisa S Klein-Gitelman
Journal:  Nat Rev Rheumatol       Date:  2011-03-08       Impact factor: 20.543

3.  Safety and efficacy of combined cyclophosphamide and rituximab treatment in recalcitrant childhood lupus.

Authors:  Ashwaq Ale'ed; Abdullah Alsonbul; Sulaiman M Al-Mayouf
Journal:  Rheumatol Int       Date:  2013-11-12       Impact factor: 2.631

4.  Efficacy and safety of rituximab for systemic lupus erythematosus treatment: a meta-analysis.

Authors:  Shanshan Wu; Yanhai Wang; Jiaojiao Zhang; Bo Han; Baishan Wang; Wanli Gao; Ning Zhang; Cheng Zhang; Feng Yan; Zhijing Li
Journal:  Afr Health Sci       Date:  2020-06       Impact factor: 0.927

5.  Rituximab therapy for juvenile-onset systemic lupus erythematosus.

Authors:  Obioma Nwobi; Carolyn L Abitbol; Jayanthi Chandar; Wacharee Seeherunvong; Gastón Zilleruelo
Journal:  Pediatr Nephrol       Date:  2007-12-19       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.